New drug clinical trial initiation time reduction
Year-over-year reduction in average time required to initiate new drug clinical trials.
Unit months Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
New drug clinical trial initiation time reduction
China, 2025
Every record
All records
1 record · 1 region · 2025
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升 | NHSA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). New drug clinical trial initiation time reduction. Retrieved from https://statorigin.org/indicators/new-drug-clinical-trial-initiation-time-reduction